Analgesics in the Czech Republic

Analgesics in the Czech Republic

Among OTC products, analgesics are among the highest in demand. In the previous year, analgesics experienced considerable growth as a result of the COVID-19 outbreak, with both adult and paediatric analgesics performing well. Concerns about COVID-19 led to panic buying in early March and continued stockpiling of certain medicines throughout the first half of 2020. During the third wave of COVID-19 in March 2021 the scenario was quite different, as consumers still had stocks of analgesics, mainly...

Euromonitor International's Analgesics in Czech Republic report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Analgesics in the Czech Republic
Euromonitor International
September 2021
List Of Contents And Tables
ANALGESICS IN THE CZECH REPUBLIC
KEY DATA FINDINGS
2021 DEVELOPMENTS
Stockpiling in the early stages of the pandemic negatively impacts sales of analgesics in 2021
Topical analgesics continue to do well in 2021
Sanofi retains its lead, supported by its strong reputation and consumer trust
PROSPECTS AND OPPORTUNITIES
Stabilisation in consumption patterns expected from 2022 as consumers resume pre-pandemic routines
Stronger shift towards e-commerce unlikely as Czech consumers show a strong preference for store-based pharmacies
Paediatric segment expected to see growth for both acetaminophen and ibuprofen
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2016-2021
Table 2 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Analgesics: % Value 2017-2021
Table 4 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 5 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN THE CZECH REPUBLIC
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What’s next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format: % Value 2016-2021
Table 15 Distribution of Consumer Health by Format and Category: % Value 2021
Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2020-2021
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook